Tower Cold Chain Solutions joins Pharma.Aero
Tower Cold Chain Solutions, Cold Chain Technologies, and Sonoco ThermoSafe join Pharma.Aero as new associate partners.
- Cold Chain Technologies and Sonoco ThermoSafe are the other associate partners to join Pharma.Aero.
February 09, 2021: Tower Cold Chain Solutions, Cold Chain Technologies, and Sonoco ThermoSafe join Pharma.Aero as new associate partners.
“The market knowledge and expertise of our three new associate partners in terms of their cold chain packaging solutions, service and product offerings will strengthen the entire Pharma.Aero family and further enhance our thought leadership in the pharmaceutical supply chain management,” said Nathan De Valck, chairman of Pharma.Aero.
Niall Balfour, CEO of TOWER Cold Chain Solutions added, “TOWER is globally recognised as being one of the most innovative providers of reusable cold chain packaging solutions to the pharmaceutical industry. We are therefore delighted to be accepted as a member of Pharma.Aero which will allow us to further enhance our relationships and collaborate with some of the largest providers within this market.”
“We are pleased to join the Pharma.Aero collaborative community,” said Ron Haub, segment director at Sonoco ThermoSafe. “Together with the other key stakeholders in the air cargo supply chain, we look forward to contributing our longstanding technical depth in temperature-controlled packaging to further drive continuous improvement in the pharmaceutical and life sciences air transport ecosystem.”
Kristian Williams, regional sales director of EMEA at Cold Chain Technologies cited, “As a global leader in the development and delivery of cost-effective insulated thermal packaging solutions, it is imperative that we strive to achieve excellence throughout the temperature-controlled supply chain. Joining Pharma.Aero gives us the platform to effectively collaborate with partners and stakeholders to ensure we continue to meet the specific requirements for transporting lifesaving temperature sensitive products to patients across the globe. The platform for collaboration that is available to the Pharma.Aero members will support the innovation and growth goals that we have within Europe and globally.”